NO174101C - Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater - Google Patents

Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater

Info

Publication number
NO174101C
NO174101C NO893248A NO893248A NO174101C NO 174101 C NO174101 C NO 174101C NO 893248 A NO893248 A NO 893248A NO 893248 A NO893248 A NO 893248A NO 174101 C NO174101 C NO 174101C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogous procedure
triazole derivatives
active triazole
Prior art date
Application number
NO893248A
Other languages
English (en)
Other versions
NO893248L (no
NO174101B (no
NO893248D0 (no
Inventor
Roger Peter Dickinson
Kenneth Richardson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10642109&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO174101(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of NO893248D0 publication Critical patent/NO893248D0/no
Publication of NO893248L publication Critical patent/NO893248L/no
Publication of NO174101B publication Critical patent/NO174101B/no
Publication of NO174101C publication Critical patent/NO174101C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO893248A 1988-08-13 1989-08-11 Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater NO174101C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888819308A GB8819308D0 (en) 1988-08-13 1988-08-13 Triazole antifungal agents

Publications (4)

Publication Number Publication Date
NO893248D0 NO893248D0 (no) 1989-08-11
NO893248L NO893248L (no) 1990-02-14
NO174101B NO174101B (no) 1993-12-06
NO174101C true NO174101C (no) 1994-03-16

Family

ID=10642109

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893248A NO174101C (no) 1988-08-13 1989-08-11 Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater

Country Status (39)

Country Link
US (2) US5116844A (no)
EP (1) EP0357241B1 (no)
JP (2) JPH0786100B2 (no)
KR (1) KR930002729B1 (no)
CN (1) CN1029231C (no)
AP (1) AP104A (no)
AR (1) AR246963A1 (no)
AU (1) AU602638B2 (no)
BG (1) BG60865B1 (no)
CA (1) CA1341325C (no)
CY (1) CY1968A (no)
CZ (1) CZ284318B6 (no)
DD (1) DD284010A5 (no)
DE (1) DE68913105T2 (no)
DK (1) DK172471B1 (no)
ES (1) ES2062009T4 (no)
FI (1) FI96859C (no)
GB (1) GB8819308D0 (no)
HK (1) HK1000320A1 (no)
HU (2) HU205348B (no)
IE (1) IE61412B1 (no)
IL (1) IL91231A (no)
IN (1) IN175438B (no)
IS (1) IS1586B (no)
LV (1) LV10714B (no)
MA (1) MA21610A1 (no)
MX (1) MX17169A (no)
MY (1) MY105092A (no)
NO (1) NO174101C (no)
NZ (1) NZ230283A (no)
OA (1) OA09126A (no)
PE (1) PE1591A1 (no)
PL (2) PL163756B1 (no)
PT (1) PT91440B (no)
RO (1) RO108453B1 (no)
RU (2) RU1836366C (no)
SK (1) SK280775B6 (no)
YU (1) YU47093B (no)
ZA (1) ZA896151B (no)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620342B2 (en) * 1987-09-24 1992-02-20 Philip Morris Products Inc. Smoking compositions containing a heteroaromatic flavorant-release additive
HUT53889A (en) * 1988-03-04 1990-12-28 Sankyo Co. Ltd.,Jp Fungicides comprising triazole derivatives as active ingredient and process for producing the active ingredient
US5278175A (en) * 1990-02-02 1994-01-11 Pfizer Inc. Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
GB9107055D0 (en) * 1991-04-04 1991-05-22 Pfizer Ltd Triazole antifungal agents
US5493024A (en) * 1991-04-11 1996-02-20 Dowelanco 3,4,N-trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insectioides
GB9121456D0 (en) * 1991-10-10 1991-11-27 Pfizer Ltd Triazole antifungal agents
GB9317491D0 (en) * 1993-08-23 1993-10-06 Fujisawa Pharmaceutical Co New compound and a process for preparation thereof
SE508401C2 (sv) * 1993-06-09 1998-10-05 Sca Hygiene Prod Ab Absorberande struktur och absorberande alster, som innefattar strukturen ifråga
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
CA2145458A1 (en) * 1994-03-28 1995-09-29 Hiroki Kodama Triazole compound and production process and use thereof
GB9512961D0 (en) * 1995-06-26 1995-08-30 Pfizer Ltd Antifungal agents
CA2180091A1 (en) * 1995-07-08 1997-01-09 Hiroki Kodama Optically active triazole derivative, process for producing the same, antifungal agent, and method for using the same
KR100423590B1 (ko) * 1995-08-02 2004-09-10 호따. 우리아치에씨아. 에세. 아. 항진균활성을갖는신규피리미돈유도체
ES2107376B1 (es) * 1995-08-02 1998-07-01 Uriach & Cia Sa J Nuevos derivados de pirimidona con actividad antifungica.
EP0783502A1 (en) * 1995-08-02 1997-07-16 J. URIACH & CIA. S.A. New carboxamides with antifungal activity
GB9516121D0 (en) 1995-08-05 1995-10-04 Pfizer Ltd Organometallic addition to ketones
GB9605705D0 (en) * 1996-03-19 1996-05-22 Pfizer Ltd Therapeutic agents
US7193083B2 (en) * 1996-07-26 2007-03-20 Pfizer, Inc. Preparation of triazoles by organometallic addition to ketones and intermediates therefor
DE19725450A1 (de) 1997-06-16 1998-12-17 Hoechst Schering Agrevo Gmbh 4-Haloalkyl-3-heterocyclylpyridine und 4-Haloalkyl-5-heterocyclylpyrimidine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
US6699853B2 (en) 1997-06-16 2004-03-02 Hoechst Schering Agrevo Gmbh 4-haloalkyl-3-heterocyclylpyridines, 4-haloalkyl-5-heterocyclyl-pyrimidines and 4-trifluoromethyl-3-oxadiazolylpyridines, processes for their preparation, compositions comprising them, and their use as pesticides
GB9713149D0 (en) * 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
ES2159488B1 (es) * 2000-03-07 2002-04-16 Uriach & Cia Sa J Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica.
FR2814073B1 (fr) * 2000-09-21 2005-06-24 Yang Ji Chemical Company Ltd Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux derives de l'indole a titre de principes actifs d'une telle composition
KR100572996B1 (ko) * 2003-08-12 2006-04-25 한국화학연구원 불소화 비닐 에테르 측쇄기를 갖는 아졸계 살균제 화합물및 그의 제조방법
AR061889A1 (es) 2006-07-13 2008-10-01 Medichem Sa Proceso mejorado para la preparacion de voriconazol
ES2652670T3 (es) 2006-08-07 2018-02-05 Palau Pharma, S.A. Compuestos antifúngicos cristalinos
US20110224232A1 (en) * 2008-05-06 2011-09-15 Board Of Regents, The University Of Texas System Treatment of Pulmonary Fungal Infection With Voriconazole via Inhalation
MX2012000212A (es) * 2009-07-08 2012-01-25 Bayer Cropscience Ag Derivados de fenil (oxi/tio) alcanol sustituidos.
WO2011064558A2 (en) 2009-11-30 2011-06-03 Cipla Limited Pharmaceutical composition
WO2011110198A1 (en) 2010-03-10 2011-09-15 Synthron B.V. A process for making voriconazole
CA2837400C (en) * 2010-04-24 2017-12-12 Viamet Pharmaceuticals, Inc. 5-(optionally substituted phenyl) pyridin-2-yl compounds as metalloenzyme inhibitors
EP2632903A4 (en) * 2010-10-28 2014-11-26 Viamet Pharmaceuticals Inc METALLOENZYMHEMMERVERBINDUNGEN
RU2478106C2 (ru) * 2010-11-25 2013-03-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) СОЕДИНЕНИЯ НА ОСНОВЕ КОМПЛЕКСОВ ГИПЕРРАЗВЕТВЛЕННЫХ ПОЛИМЕРОВ Boltorn H, ОБЛАДАЮЩИЕ АНТИКАНДИДОЗНОЙ АКТИВНОСТЬЮ, И СПОСОБ ИХ ПОЛУЧЕНИЯ
US20140350252A1 (en) 2011-02-21 2014-11-27 Nitin Maheshwari Process for the preparation of voriconazole and intermediates thereof
EP2720723B1 (en) 2011-06-15 2018-04-11 Synthon BV Stabilized voriconazole composition
CN105884743B (zh) 2011-06-19 2019-08-06 威尔金制药(Nc)有限公司 金属酶抑制剂化合物
EA024385B1 (ru) * 2011-06-19 2016-09-30 Ваймет Фармасьютикалс, Инк. Соединения, ингибирующие металлоферменты
KR101964195B1 (ko) 2011-06-23 2019-04-01 비아멧 파마슈티컬즈(엔씨), 인코포레이티드 금속효소 억제제 화합물
TWI658039B (zh) * 2011-07-08 2019-05-01 維愛美製藥公司 金屬酶抑制劑化合物
TWI646088B (zh) * 2012-03-16 2019-01-01 維愛美製藥公司 金屬酶抑制劑化合物
AU2013257830A1 (en) 2012-05-11 2014-11-20 Cipla Limited Pharmaceutical composition
CN102796087B (zh) * 2012-09-04 2015-04-15 西南大学 香豆素三唑醇及其制备方法和用途
US20150246898A1 (en) * 2012-09-12 2015-09-03 Dow Agrosciences Llc Metalloenzyme inhibitor compounds
CN104884450B (zh) 2012-10-15 2017-03-29 辉瑞爱尔兰制药公司 制备伏立康唑及其类似物的方法
US9447073B2 (en) 2013-05-28 2016-09-20 Viamet Pharmaceuticals, Inc. Fungicidal compositions
RU2563811C1 (ru) * 2014-08-08 2015-09-20 Федеральное государственное бюджетное учреждение науки Институт химической физики им. Н.Н. Семенова Российской академии наук (ИХФ РАН) Фармацевтическая композиция для лечения грибковых заболеваний
BR112017006666A2 (pt) * 2014-10-02 2018-01-02 Bayer Cropscience Ag novos derivados de triazole úteis como fungicidas.
US11051514B2 (en) 2015-05-18 2021-07-06 Mycovia Pharmaceuticals, Inc. Antifungal compounds
CA3104291A1 (en) 2018-06-21 2019-12-26 Yumanity Therapeutics, Inc. Compositions and methods for the treatment and prevention of neurological disorders

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3175673D1 (en) * 1980-11-19 1987-01-15 Ici Plc Triazole compounds, a process for preparing them, their use as plant fungicides and fungicidal compositions containing them
US4510148A (en) * 1982-06-12 1985-04-09 Pfizer Inc. 2-Heterocyclic-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ols as antifungal agents
DE3228870A1 (de) * 1982-08-03 1984-02-09 Bayer Ag, 5090 Leverkusen Diazolyl-alkanole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
DE3242236A1 (de) * 1982-11-15 1984-05-17 Bayer Ag, 5090 Leverkusen "antimykotische mittel"
DE3242252A1 (de) * 1982-11-15 1984-05-17 Bayer Ag, 5090 Leverkusen Heterocyclisch substituierte hydroxyalkyl-azolyl-derivate
GB8304282D0 (en) * 1983-02-16 1983-03-23 Pfizer Ltd Antifungal agents
DE3307218A1 (de) * 1983-03-02 1984-09-06 Bayer Ag, 5090 Leverkusen Substituierte diazolylalkyl-carbinole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
GB8306351D0 (en) * 1983-03-08 1983-04-13 Ici Plc Azole fungicides
DK159205C (da) * 1983-03-16 1991-03-04 Pfizer Bis(triazol)alkanol-forbindelser, anvendelse af disse, farmaceutiske praeparater og landbrugsfungicider indeholdende disse og fremgangsmaade til behandling af planter eller froe, som har en svampeinfektion
GB8307232D0 (en) * 1983-03-16 1983-04-20 Pfizer Ltd Antifungal agents
GB8313235D0 (en) * 1983-05-13 1983-06-22 Pfizer Ltd Antifungal agents
DE3325313A1 (de) * 1983-07-13 1985-01-31 Bayer Ag, 5090 Leverkusen Fungizide mittel, deren herstellung und verwendung
US4483863A (en) * 1984-01-20 1984-11-20 Pfizer Inc. Triazole antifungal agents
IE58738B1 (en) * 1984-09-05 1993-11-03 Ici Plc Antifungal azole compounds
DE3440117A1 (de) * 1984-11-02 1986-05-15 Bayer Ag, 5090 Leverkusen Substituierte azolylcyclopropyl-azolylmethyl-carbinol-derivate
GB8506619D0 (en) * 1985-03-14 1985-04-17 Pfizer Ltd Triazole antifungal agents
JPS6360975A (ja) * 1986-06-23 1988-03-17 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー 抗真菌性カルビノ−ル類
DE3813841A1 (de) * 1987-06-03 1988-12-15 Bayer Ag Heterocyclische hydroxyethylazole
GB8716651D0 (en) * 1987-07-15 1987-08-19 Ici Plc 2-propanol derivatives
HUT53889A (en) * 1988-03-04 1990-12-28 Sankyo Co. Ltd.,Jp Fungicides comprising triazole derivatives as active ingredient and process for producing the active ingredient

Also Published As

Publication number Publication date
YU47093B (sh) 1994-12-28
MA21610A1 (fr) 1990-04-01
CN1040795A (zh) 1990-03-28
SK476189A3 (en) 2000-07-11
IS1586B (is) 1996-03-01
NO893248L (no) 1990-02-14
NO174101B (no) 1993-12-06
HU211511A9 (en) 1995-11-28
IS3499A7 (is) 1990-02-14
EP0357241B1 (en) 1994-02-16
CN1029231C (zh) 1995-07-05
DK394589A (da) 1990-02-14
AR246963A1 (es) 1994-10-31
DE68913105T2 (de) 1994-05-26
FI96859B (fi) 1996-05-31
SK280775B6 (sk) 2000-07-11
BG60865B1 (bg) 1996-05-31
PL163756B1 (pl) 1994-04-29
IL91231A (en) 1994-08-26
ES2062009T3 (es) 1994-12-16
YU158789A (en) 1991-04-30
CZ284318B6 (cs) 1998-10-14
NO893248D0 (no) 1989-08-11
US5116844A (en) 1992-05-26
CZ476189A3 (cs) 1998-09-16
JP2713394B2 (ja) 1998-02-16
HUT52089A (en) 1990-06-28
US5364938A (en) 1994-11-15
GB8819308D0 (en) 1988-09-14
AP8900135A0 (en) 1989-10-31
MY105092A (en) 1994-08-30
FI96859C (fi) 1996-09-10
AU3893089A (en) 1990-03-22
JPH02104583A (ja) 1990-04-17
NZ230283A (en) 1991-02-26
ZA896151B (en) 1991-03-27
FI893809A0 (fi) 1989-08-11
DE68913105D1 (de) 1994-03-24
PT91440A (pt) 1990-03-08
IE892582L (en) 1990-02-13
DD284010A5 (de) 1990-10-31
PL162953B1 (pl) 1994-01-31
JPH0786100B2 (ja) 1995-09-20
LV10714B (en) 1995-12-20
CA1341325C (en) 2001-12-11
PT91440B (pt) 1995-05-04
MX17169A (es) 1993-08-01
IE61412B1 (en) 1994-11-02
HK1000320A1 (en) 1998-02-27
JPH07173154A (ja) 1995-07-11
AU602638B2 (en) 1990-10-18
EP0357241A1 (en) 1990-03-07
IN175438B (no) 1995-06-17
DK172471B1 (da) 1998-09-07
FI893809A (fi) 1990-02-14
HU205348B (en) 1992-04-28
RO108453B1 (ro) 1994-05-31
ES2062009T4 (es) 2006-07-01
KR900003157A (ko) 1990-03-23
PE1591A1 (es) 1991-03-16
IL91231A0 (en) 1990-03-19
LV10714A (lv) 1995-06-20
RU2095358C1 (ru) 1997-11-10
DK394589D0 (da) 1989-08-11
OA09126A (fr) 1991-10-31
RU1836366C (ru) 1993-08-23
KR930002729B1 (ko) 1993-04-09
AP104A (en) 1990-11-02
CY1968A (en) 1997-09-05

Similar Documents

Publication Publication Date Title
NO174101C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater
NO176796C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater
NO172540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrrolderivater
NO170483C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrahydronaftalin- og indanderivater
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO180586C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler
NO179283C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO170884C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO174467C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO175429C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 16-dehydro-vitamin-D3-derivater
NO171507C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
NO178069C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive platinakomplekser
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO174391C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO168037C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater.
NO171065C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO172643C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater

Legal Events

Date Code Title Description
MK1K Patent expired